NCT02851485View on ClinicalTrials.gov

Bioavailability Study With GLPG1972

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Osteoarthritis
Interventions
DRUG

GLPG1972 600 mg oral solution fasted

dosing after overnight fasting

DRUG

GLPG1972 600 mg oral tablet fasted

dosing after overnight fasting

DRUG

GLPG1972 600 mg oral tablet fed

dosing after high-fat high-calorie breakfast

Trial Locations (1)

Unknown

PRA-EDS, Zuidlaren

Sponsors

Lead Sponsor

Galapagos NV

Collaborators (1)

PRA Health Sciences
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Galapagos NV

INDUSTRY